Copyright Reports & Markets. All rights reserved.

Global Cancer (Tumor) Profiling Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Cancer (Tumor) Profiling Industry
  • 1.7 COVID-19 Impact: Cancer (Tumor) Profiling Market Trends

    • 2 Global Cancer (Tumor) Profiling Quarterly Market Size Analysis

    • 2.1 Cancer (Tumor) Profiling Business Impact Assessment - COVID-19
      • 2.1.1 Global Cancer (Tumor) Profiling Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Cancer (Tumor) Profiling Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Cancer (Tumor) Profiling Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Cancer (Tumor) Profiling Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Cancer (Tumor) Profiling Market
    • 3.4 Key Players Cancer (Tumor) Profiling Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Cancer (Tumor) Profiling Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Immunoassay
      • 1.4.2 Hybridization
      • 1.4.3 NGS
      • 1.4.4 Mass Spectrometry
    • 4.2 By Type, Global Cancer (Tumor) Profiling Market Size, 2019-2021

    5 Impact of Covid-19 on Cancer (Tumor) Profiling Segments, By Application

    • 5.1 Overview
      • 5.5.1 Clinical
      • 5.5.2 Research
    • 5.2 By Application, Global Cancer (Tumor) Profiling Market Size, 2019-2021
      • 5.2.1 By Application, Global Cancer (Tumor) Profiling Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Illumina
      • 7.1.1 Illumina Business Overview
      • 7.1.2 Illumina Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.1.3 Illumina Cancer (Tumor) Profiling Product Introduction
      • 7.1.4 Illumina Response to COVID-19 and Related Developments
    • 7.2 Qiagen
      • 7.2.1 Qiagen Business Overview
      • 7.2.2 Qiagen Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.2.3 Qiagen Cancer (Tumor) Profiling Product Introduction
      • 7.2.4 Qiagen Response to COVID-19 and Related Developments
    • 7.3 Neogenomics Laboratories
      • 7.3.1 Neogenomics Laboratories Business Overview
      • 7.3.2 Neogenomics Laboratories Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Product Introduction
      • 7.3.4 Neogenomics Laboratories Response to COVID-19 and Related Developments
    • 7.4 HTG Molecular Diagnostics
      • 7.4.1 HTG Molecular Diagnostics Business Overview
      • 7.4.2 HTG Molecular Diagnostics Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Product Introduction
      • 7.4.4 HTG Molecular Diagnostics Response to COVID-19 and Related Developments
    • 7.5 Genomic Health
      • 7.5.1 Genomic Health Business Overview
      • 7.5.2 Genomic Health Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.5.3 Genomic Health Cancer (Tumor) Profiling Product Introduction
      • 7.5.4 Genomic Health Response to COVID-19 and Related Developments
    • 7.6 Caris Life Sciences
      • 7.6.1 Caris Life Sciences Business Overview
      • 7.6.2 Caris Life Sciences Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.6.3 Caris Life Sciences Cancer (Tumor) Profiling Product Introduction
      • 7.6.4 Caris Life Sciences Response to COVID-19 and Related Developments
    • 7.7 Helomics Corporation
      • 7.7.1 Helomics Corporation Business Overview
      • 7.7.2 Helomics Corporation Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.7.3 Helomics Corporation Cancer (Tumor) Profiling Product Introduction
      • 7.7.4 Helomics Corporation Response to COVID-19 and Related Developments
    • 7.8 Nanostring Technologies
      • 7.8.1 Nanostring Technologies Business Overview
      • 7.8.2 Nanostring Technologies Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.8.3 Nanostring Technologies Cancer (Tumor) Profiling Product Introduction
      • 7.8.4 Nanostring Technologies Response to COVID-19 and Related Developments
    • 7.9 Oxford Gene Technology
      • 7.9.1 Oxford Gene Technology Business Overview
      • 7.9.2 Oxford Gene Technology Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Product Introduction
      • 7.9.4 Oxford Gene Technology Response to COVID-19 and Related Developments
    • 7.10 Ribomed Biotechnologies
      • 7.10.1 Ribomed Biotechnologies Business Overview
      • 7.10.2 Ribomed Biotechnologies Cancer (Tumor) Profiling Quarterly Revenue, 2020
      • 7.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Product Introduction
      • 7.10.4 Ribomed Biotechnologies Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Cancer (Tumor) Profiling, including the following market information:
      Global Cancer (Tumor) Profiling Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cancer (Tumor) Profiling Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cancer (Tumor) Profiling Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Cancer (Tumor) Profiling Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Illumina, Qiagen, Neogenomics Laboratories, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics Corporation, Nanostring Technologies, Oxford Gene Technology, Ribomed Biotechnologies, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Immunoassay
      Hybridization
      NGS
      Mass Spectrometry

      Based on the Application:
      Clinical
      Research

      Buy now